Skip to Content

GSI 705 (Truvada 167 mg / 250 mg)

Generic Name: emtricitabine/tenofovir

Pill imprint GSI 705 has been identified as Truvada 167 mg / 250 mg.

Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 167 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Truvada
Generic Name:
emtricitabine/tenofovir
Imprint:
GSI 705
Strength:
167 mg / 250 mg
Color:
Blue
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Gilead Sciences, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide